Revolution Medicines's three largest insider shareholders as of May 04, 2026 are Rock Ventures Iii, L.P. Third (TenPercentOwner, 5.10Mn shares), Thilo Schroeder (Director, 4.74Mn shares), Thilo Schroeder (Director, 2.86Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Rock Ventures Iii, L.P. Third | - | 5,104,130 | 0 | 10 Jun, 2022 |
| Rock Ventures Iii, L.P. Third | - | 5,104,130 | 0 | 10 Jun, 2022 |
| Thilo Schroeder | - | 0 | 4,743,606 | 14 Nov, 2023 |
| Thilo Schroeder | - | 0 | 2,857,481 | 09 Dec, 2024 |
| Alexis Borisy | - | 2,338,884 | 0 | 30 Jun, 2025 |
| Thilo Schroeder | - | 0 | 484,665 | 09 Mar, 2022 |
| Stephen Michael Kelsey | - | 295,398 | 0 | 19 Mar, 2026 |
| Mark A Goldsmith | - | 276,698 | 0 | 17 Apr, 2026 |
| Margaret A Horn | Chief Operating Officer | 157,570 | 0 | 19 Mar, 2026 |
| Jack Anders | Chief Financial Officer | 125,512 | 0 | 19 Mar, 2026 |
| Xiaolin Wang | - | 116,063 | 0 | 19 Mar, 2026 |
| Xiaolin Wang | - | 116,063 | 0 | 19 Mar, 2026 |
| Lin Wei | Chief Medical Officer | 101,366 | 0 | 19 Mar, 2026 |
| Lin Wei | Chief Medical Officer | 101,366 | 0 | 19 Mar, 2026 |
| Sandra Horning | - | 96,574 | 0 | 30 Jun, 2025 |
| Lorence H. Kim | - | 73,090 | 0 | 30 Jun, 2025 |
| Mark A Goldsmith | - | 0 | 64,424 | 03 Mar, 2026 |
| Jeff Cislini | General Counsel | 58,518 | 0 | 19 Mar, 2026 |
| Anthony Mancini | - | 54,400 | 0 | 26 Mar, 2026 |
| Neil Exter | - | 28,815 | 0 | 17 Jun, 2022 |
| Flavia Borellini | - | 25,024 | 0 | 30 Jun, 2025 |
| Elizabeth M Anderson | - | 8,215 | 15,000 | 06 Mar, 2026 |
| Sushil Patel | - | 23,090 | 0 | 30 Jun, 2025 |
| Eric Thomas Schmidt | - | 21,251 | 0 | 12 Jun, 2023 |
| Eric Thomas Schmidt | - | 21,251 | 0 | 12 Jun, 2023 |
| Barbara Weber | - | 13,065 | 0 | 10 Oct, 2024 |
| Barbara Weber | - | 13,065 | 0 | 10 Oct, 2024 |
| Frank Clyburn | - | 9,738 | 0 | 30 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | Mark A Goldsmith | Common Stock | A | 23,244 | $4.09 | 299,942 | D | M |
| 15 Apr, 2026 | Mark A Goldsmith | Common Stock | A | 96,756 | $4.73 | 396,698 | D | M |
| 15 Apr, 2026 | Mark A Goldsmith | Common Stock | D | 120,000 | $150.09 | 276,698 | D | S |
| 15 Apr, 2026 | Mark A Goldsmith | Stock Option (Right to Buy) | D | 23,244 | $0.00 | 24,464 | D | M |
| 15 Apr, 2026 | Mark A Goldsmith | Stock Option (Right to Buy) | D | 96,756 | $0.00 | 424,085 | D | M |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | A | 37,450 | $33.62 | 91,850 | D | M |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | D | 1,800 | $93.22 | 90,050 | D | S |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | D | 3,128 | $94.16 | 86,922 | D | S |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | D | 21,086 | $95.49 | 65,836 | D | S |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | D | 11,036 | $96.43 | 54,800 | D | S |
| 25 Mar, 2026 | Anthony Mancini | Common Stock | D | 400 | $97.21 | 54,400 | D | S |
| 25 Mar, 2026 | Anthony Mancini | Stock Option (Right to Buy) | D | 37,450 | $0.00 | 112,350 | D | M |
| 17 Mar, 2026 | Jeff Cislini | Common Stock | D | 1,795 | $99.48 | 59,681 | D | S |
| 17 Mar, 2026 | Xiaolin Wang | Common Stock | D | 2,010 | $99.48 | 116,063 | D | S |
| 17 Mar, 2026 | Lin Wei | Common Stock | D | 2,073 | $99.48 | 101,366 | D | S |
| 17 Mar, 2026 | Margaret A Horn | Common Stock | D | 4,583 | $99.48 | 157,570 | D | S |
| 17 Mar, 2026 | Lin Wei | Common Stock | D | 2,073 | $99.48 | 101,366 | D | S |
| 17 Mar, 2026 | Xiaolin Wang | Common Stock | D | 2,010 | $99.48 | 116,063 | D | S |
| 17 Mar, 2026 | Mark A Goldsmith | Common Stock | D | 12,871 | $99.48 | 276,698 | D | S |
| 17 Mar, 2026 | Jack Anders | Common Stock | D | 2,753 | $99.48 | 125,512 | D | S |